Weekly administration of paclitaxel: theoretical and clinical basis.
about
Weekly versus tri-weekly paclitaxel with carboplatin for first-line treatment in women with ovarian cancerLysophosphatidate induces chemo-resistance by releasing breast cancer cells from taxol-induced mitotic arrestBioinformatic analyses identifies novel protein-coding pharmacogenomic markers associated with paclitaxel sensitivity in NCI60 cancer cell lines.Phase I study of pazopanib in combination with weekly paclitaxel in patients with advanced solid tumors.Should tumor VEGF expression influence decisions on combining low-dose chemotherapy with antiangiogenic therapy? Preclinical modeling in ovarian cancer.The therapeutic potential of a series of orally bioavailable anti-angiogenic microtubule disruptors as therapy for hormone-independent prostate and breast cancers.Modulating microtubule stability enhances the cytotoxic response of cancer cells to PaclitaxelEfficacy of weekly paclitaxel treatment as a single agent chemotherapy following first-line cisplatin treatment in urothelial bladder cancer.Level of evidence for therapeutic drug monitoring of taxanes.Suicidal gene therapy in the effective control of primary human hepatocellular carcinoma as monitored by noninvasive bioimaging.Effectiveness of liposomal paclitaxel against MCF-7 breast cancer cells.Weekly paclitaxel as metronomic palliative chemotherapy in small cell lung cancer.Paclitaxel and Its Evolving Role in the Management of Ovarian Cancer.Intratracheal budesonide-poly(lactide-co-glycolide) microparticles reduce oxidative stress, VEGF expression, and vascular leakage in a benzo(a)pyrene-fed mouse model.Pharmacogenetics of response to neoadjuvant paclitaxel treatment for locally advanced breast cancer.Characteristics, Properties and Analytical Methods of Paclitaxel: A Review.A phase Ib study of preoperative lapatinib, paclitaxel, and gemcitabine combination therapy in women with HER2 positive early breast cancer.Weekly versus 3-weekly paclitaxel in combination with carboplatin in advanced ovarian cancer: which is the optimal adjuvant chemotherapy regimen?
P2860
Q24187365-82A4803C-7667-47B6-927F-86661646F826Q28478339-D9DC8951-0AF8-433B-8511-E5D729D8F589Q33818738-F247160E-8E35-402A-8243-6FC6FC05A146Q35583837-7A7CD077-8D81-4669-B521-D055C13F37A5Q36449367-C1327845-826B-4340-9B28-9B3A53B7866EQ36610771-E250A426-E9E7-4DBD-84C4-581A7626153AQ36920871-8D6C6B34-93E0-4344-B57E-9967D3B4615DQ36953789-55AB0AD3-3F1C-44E4-91C6-378C57F10568Q37788732-772941EE-1B64-4E9A-851E-36A018E20208Q39473687-1F20E58F-8366-472C-B33C-322E76B5D6CCQ39619164-0999F349-822A-447D-A109-58D2AE536DC1Q39701080-50F68F27-4EEA-4580-80D1-4901AD3E6FDAQ41897007-138D837E-305C-498D-B7BD-DED5B98DFD34Q46207350-4EC4C5EE-38CD-42A3-8674-AB8A48F7019BQ47241273-DDAC6739-FB1B-4032-809F-65594EB73296Q47756052-910E3196-5417-467E-81D5-BD2F920DF202Q53402025-ABF368F9-EEC3-4460-800F-9C7275189CEEQ58766423-6526FA13-477D-4114-8084-D06284E4A500
P2860
Weekly administration of paclitaxel: theoretical and clinical basis.
description
2002 nî lūn-bûn
@nan
2002 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Weekly administration of paclitaxel: theoretical and clinical basis.
@ast
Weekly administration of paclitaxel: theoretical and clinical basis.
@en
type
label
Weekly administration of paclitaxel: theoretical and clinical basis.
@ast
Weekly administration of paclitaxel: theoretical and clinical basis.
@en
prefLabel
Weekly administration of paclitaxel: theoretical and clinical basis.
@ast
Weekly administration of paclitaxel: theoretical and clinical basis.
@en
P2093
P1476
Weekly administration of paclitaxel: theoretical and clinical basis.
@en
P2093
Corrado Ficorella
Giancarlo Antonini Cappellini
Graziana Ronzino
Paolo Marchetti
Saïk Urien
P356
10.1016/S1040-8428(02)00109-9
P478
P50
P577
2002-12-01T00:00:00Z